search
Back to results

Systemic Hypothermia Improves Outcome of Hypoxic-Ischemic Encephalopathy

Primary Purpose

Hypoxic-Ischemic Encephalopathy

Status
Completed
Phase
Phase 1
Locations
China
Study Type
Interventional
Intervention
hypothermia
Sponsored by
Zhengzhou University
About
Eligibility
Locations
Outcomes
Full info

About this trial

This is an interventional prevention trial for Hypoxic-Ischemic Encephalopathy focused on measuring asphyxia, hypothermia, hypoxic-ischemic encephalopathy, neonates

Eligibility Criteria

1 Hour - 10 Hours (Child)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  1. Gestation age ≥37 weeks and body weight >2500g.
  2. with one of the following factors:

    1. Apgar score<5 at 5min;
    2. Assisted respiration >3min due to respiratory distress;
    3. pH≤7.1 of cord or arterial blood within 60min after birth;
    4. clinical manifestation of encephalopathy during the first 10 hrs of life.

Exclusion Criteria:

  1. Major congenital abnormalities;
  2. Head trauma or skull fracture causing major intracranial hemorrhage;
  3. Mild HIE;
  4. Financial problems of the parents;
  5. Lack of permanent address;
  6. Postnatal age > 10 hrs

Sites / Locations

  • NICU, the Third Affiliated Hospital, Zhengzhou University

Outcomes

Primary Outcome Measures

Mortality and disability rate.

Secondary Outcome Measures

Full Information

First Posted
January 2, 2009
Last Updated
January 5, 2009
Sponsor
Zhengzhou University
Collaborators
Medical University Innsbruck
search

1. Study Identification

Unique Protocol Identification Number
NCT00817401
Brief Title
Systemic Hypothermia Improves Outcome of Hypoxic-Ischemic Encephalopathy
Official Title
Effect of Systemic Hypothermia on Neonatal Hypoxic-Ischemic Encephalopathy
Study Type
Interventional

2. Study Status

Record Verification Date
January 2009
Overall Recruitment Status
Completed
Study Start Date
July 2002 (undefined)
Primary Completion Date
June 2008 (Actual)
Study Completion Date
June 2008 (Actual)

3. Sponsor/Collaborators

Name of the Sponsor
Zhengzhou University
Collaborators
Medical University Innsbruck

4. Oversight

Data Monitoring Committee
Yes

5. Study Description

Brief Summary
Perinatal asphyxia-induced brain injury is one of the most common causes of morbidity and mortality in term and preterm neonates. Birth asphyxia accounts for 23% of neonatal deaths globally and survivors suffer from long term neurological disability and impairment. Although many neuroprotective strategies appeared promising in animal models, most of them were not feasible and effective in human newborns. However, hypothermia was reported not to be effective if introduced beyond and thus should be introduced within 6 hrs after birth.Applying this selection criterion naturally would deprive many patients of the opportunity of hypothermia treatment.
Detailed Description
Hypoxic-ischemic encephalopathy of the newborn infant remains a significant socio-economic health problem worldwide. Moderate to severe HIE of newborn infants is associated with a high rate of death or long-term disabilities. Historically, treatment has been purely supportive including stabilizing cardio-respiratory functions and treating convulsions. Recent multi-center trials assessing the effects of hypothermia demonstrated improved outcome in term neonates with moderate hypoxic-ischemic encephalopathy (HIE). However, hypothermia was not effective beyond 6 hrs after brain injury. The aim of this study was to investigate whether systemic hypothermia induced up to 10 hrs after birth would improve the neurodevelopmental outcome at 18 months in infants with moderate or severe HIE.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Hypoxic-Ischemic Encephalopathy
Keywords
asphyxia, hypothermia, hypoxic-ischemic encephalopathy, neonates

7. Study Design

Primary Purpose
Prevention
Study Phase
Phase 1, Phase 2
Interventional Study Model
Parallel Assignment
Masking
ParticipantOutcomes Assessor
Allocation
Randomized
Enrollment
100 (Actual)

8. Arms, Groups, and Interventions

Intervention Type
Device
Intervention Name(s)
hypothermia
Other Intervention Name(s)
TS Med 200, Germany
Intervention Description
For the systemic hypothermia treatment (TS Med 200, Germany), the infants were nursed under an open unit, covered only by a diaper and a thin linen, loosing heat to the environment and to a cooling mat¬tress which was perfused by circulating liquid at a variable temperature. The rectal temperature was targeted at 33.5 °C (range of 33 to 34 °C) and was meant to be achieved within 60 min. The body temperature was checked every 10 min during induction hypothermia and every hour during the remaining period of cooling. The duration of hypothermia was 72 hrs. Rewarming was started by stopping the cooling system. The infant was meant to reach a 36.5°C rectal temperature in 6 hrs after stopping cooling to prevent rebound hyperthermia.
Primary Outcome Measure Information:
Title
Mortality and disability rate.
Time Frame
18 months

10. Eligibility

Sex
All
Minimum Age & Unit of Time
1 Hour
Maximum Age & Unit of Time
10 Hours
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Gestation age ≥37 weeks and body weight >2500g. with one of the following factors: Apgar score<5 at 5min; Assisted respiration >3min due to respiratory distress; pH≤7.1 of cord or arterial blood within 60min after birth; clinical manifestation of encephalopathy during the first 10 hrs of life. Exclusion Criteria: Major congenital abnormalities; Head trauma or skull fracture causing major intracranial hemorrhage; Mild HIE; Financial problems of the parents; Lack of permanent address; Postnatal age > 10 hrs
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Changlian Zhu, MD, PhD
Organizational Affiliation
Zhengzhou University
Official's Role
Study Director
Facility Information:
Facility Name
NICU, the Third Affiliated Hospital, Zhengzhou University
City
Zhengzhou
State/Province
Henan
ZIP/Postal Code
450052
Country
China

12. IPD Sharing Statement

Learn more about this trial

Systemic Hypothermia Improves Outcome of Hypoxic-Ischemic Encephalopathy

We'll reach out to this number within 24 hrs